F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works

Aducanumab is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some prominent experts say there’s not enough evidence it can address cognitive symptoms.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Related Posts

Must-Have Lifestyle Items in 2024

As we embrace 2024, staying ahead of the curve in lifestyle trends is key to enhancing our day-to-day living. From tech gadgets to home essentials,

Top 5 Investment Ideas for 2024

As we step into 2024, the investment landscape offers a mix of challenges and opportunities. With careful planning and strategic thinking, you can position your